Kien Hung Do

11PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsOther environmental sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 06, 2026
Real-World Outcomes of Mantle Cell Lymphoma Treated With Rituximab-Based Chemotherapy Regimens: Experience From a Single Institution in Vietnam.

|Oct 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam.

Cam Phuong Pham, Hung Kien Do, Anh Tu Do

|Aug 26, 2025
Case Report: A Bilateral Synchronous Primary Non-Small Cell Lung Cancer Patient With Two Different EGFR Mutations.

Thanh-Dung Quach, Kien Hung Do, Dinh Tung Nguyen

|Jun 12, 2025
Therapeutic Outcomes of Osimertinib in EGFR - Mutant Non-Small Cell Lung Cancer With Brain Metastases: Results From a Retrospective Study at Vietnam National Cancer Hospital.

Thi Nhu Hoa Nguyen, Quang Le Van, Phuong Nguyen Thi Bich

|May 25, 2025
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.

Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen

|Oct 29, 2024
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study.

Tu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham

Pageof 2

Frequent Collaborators

5 joint publications

Van Tai Nguyen

3 joint publications

Van Luan Pham

3 joint publications

Minh Cong Truong

2 joint publications

Ha Thanh Vu